| Individuals without diabetes | Individuals with type 2 diabetes | Individuals with type 1 diabetes |
---|---|---|---|
n = 18,500,151 | n = 1,913,503 | n = 9,397 | |
Myocardial infarction | |||
 Events (n) | 83,712 | 32,666 | 271 |
 Follow-up duration (person-years) | 84,157,841.27 | 9,193,771.11 | 44,306.51 |
 Incidence rate (per 100,000 person-years) | 99.470 | 355.306 | 611.648 |
 Model 1 | 1 (Ref.) | 1.869 (1.845–1.894) | 3.321 (2.948–3.741) |
– | 1 (Ref.) | 1.771 (1.571–1.996) | |
 Model 2 | 1 (Ref.) | 1.601 (1.580–1.623) | 2.844 (2.524–3.204) |
– | 1 (Ref.) | 1.751 (1.554–1.974) | |
 Model 2-1 | 1 (Ref.) | 1.279 (1.262–1.296) | 2.183 (1.938–2.459) |
– | 1 (Ref.) | 1.705 (1.513–1.922) | |
 Model 3 | 1 (Ref.) | 1.562 (1.540–1.583) | 2.739 (2.430–3.086) |
– | 1 (Ref.) | 1.723 (1.529–1.942) | |
 Model 4 | 1 (Ref.) | 1.418 (1.395–1.442) | 2.411 (2.138–2.718) |
– | 1 (Ref.) | 1.679 (1.490–1.893) | |
Hospitalization for HF | |||
 Events (n) | 89,173 | 36,448 | 376 |
 Follow-up duration (person-years) | 84,188,450.19 | 9,203,077.54 | 44,238.57 |
 Incidence rate (per 100,000 person-years) | 105.921 | 396.041 | 849.937 |
 Model 1 | 1 (Ref.) | 1.753 (1.731–1.774) | 3.955 (3.575–4.376) |
– | 1 (Ref.) | 2.241 (2.025–2.480) | |
 Model 2 | 1 (Ref.) | 1.606 (1.586–1.626) | 3.604 (3.257–3.988) |
– | 1 (Ref.) | 2.216 (2.002–2.453) | |
 Model 2-1 | 1 (Ref.) | 1.463 (1.445–1.482) | 3.233 (2.921–3.577) |
– | 1 (Ref.) | 2.195 (1.983–2.429) | |
 Model 3 | 1 (Ref.) | 1.578 (1.558–1.599) | 3.390 (3.063–3.752) |
– | 1 (Ref.) | 2.120 (1.915–2.348) | |
 Model 4 | 1 (Ref.) | 1.417 (1.395–1.440) | 3.024 (2.730–3.350) |
– | 1 (Ref.) | 2.105 (1.901–2.330) | |
Atrial fibrillation | |||
 Events (n) | 105,562 | 29,743 | 227 |
 Follow-up duration (person-years) | 84,127,796.33 | 9,204,929.38 | 44,425.71 |
 Incidence rate (per 100,000 person-years) | 125.478 | 323.120 | 510.965 |
 Model 1 | 1 (Ref.) | 1.268 (1.251–1.284) | 2.073 (1.820–2.361) |
– | 1 (Ref.) | 1.630 (1.430–1.857) | |
 Model 2 | 1 (Ref.) | 1.147 (1.132–1.162) | 1.885 (1.655–2.147) |
– | 1 (Ref.) | 1.636 (1.436–1.864) | |
 Model 2-1 | 1 (Ref.) | 1.046 (1.032–1.060) | 1.694 (1.487–1.929) |
– | 1 (Ref.) | 1.627 (1.427–1.853) | |
 Model 3 | 1 (Ref.) | 1.147 (1.131–1.162) | 1.829 (1.605–2.084) |
– | 1 (Ref.) | 1.587 (1.392–1.808) | |
 Model 4 | 1 (Ref.) | 1.085 (1.067–1.103) | 1.748 (1.534–1.993) |
– | 1 (Ref.) | 1.608 (1.411–1.833) | |
All-cause mortality | |||
 Events (n) | 249,622 | 94,018 | 876 |
 Follow-up duration (person-years) | 84,326,798.16 | 9,261,598.81 | 44,788.78 |
 Incidence rate (per 100,000 person-years) | 296.020 | 1015.140 | 1955.850 |
 Model 1 | 1 (Ref.) | 1.569 (1.557–1.581) | 3.145 (2.944–3.360) |
– | 1 (Ref.) | 1.990 (1.862–2.127) | |
 Model 2 | 1 (Ref.) | 1.685 (1.672–1.698) | 3.345 (3.131–3.574) |
– | 1 (Ref.) | 1.961 (1.835–2.096) | |
 Model 2-1 | 1 (Ref.) | 1.885 (1.870–1.899) | 3.801 (3.557–4.062) |
– | 1 (Ref.) | 2.002 (1.873–2.139) | |
 Model 3 | 1 (Ref.) | 1.635 (1.622–1.648) | 3.120 (2.919–3.334) |
– | 1 (Ref.) | 1.893 (1.771–2.024) | |
 Model 4 | 1 (Ref.) | 1.510 (1.495–1.525) | 2.874 (2.689–3.073) |
– | 1 (Ref.) | 1.884 (1.762–2.013) |